Literature DB >> 15487383

[Short version of the guideline "Early Detection of Breast Cancer in Germany"].

Klaus-Dieter Schulz1, Michael Koller, Wilfried Lorenz, Rolf Kreienberg, Robert Fischer, Ute-Susann Albert.   

Abstract

The aim of this evidence-, consensus- and outcome-based good clinical practice guideline is to help physicians, and women in making appropriate healthcare decisions about the early detection of breast cancer. The principle of early detection of breast cancer comprises the detection and diagnosis of pre-malignant breast tumours (UICC stage 0, carcinoma in situ) with a possible cancer risk reduction and the detection and diagnosis of breast cancer at an early stage (UICC stage 1) with a scientifically proven 90% chance of cure. By establishing a nation-wide comprehensive quality assurance program for the early detection of breast cancer this guideline lays the foundation for a timely reduction of breast cancer mortality and achievement of cure with less impairment of patient's quality of life. It would appear that this guideline makes major improvements in women's healthcare feasible.

Entities:  

Mesh:

Year:  2004        PMID: 15487383

Source DB:  PubMed          Journal:  Z Arztl Fortbild Qualitatssich        ISSN: 1431-7621


  8 in total

1.  Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology.

Authors:  Sara Y Brucker; Markus Wallwiener; Rolf Kreienberg; Walter Jonat; Matthias W Beckmann; Michael Bamberg; Diethelm Wallwiener; Rainer Souchon
Journal:  Strahlenther Onkol       Date:  2011-01-21       Impact factor: 3.621

2.  Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.

Authors:  Dorothea Gadzicki; D Gareth Evans; Hilary Harris; Claire Julian-Reynier; Irmgard Nippert; Jörg Schmidtke; Aad Tibben; Christi J van Asperen; Brigitte Schlegelberger
Journal:  J Community Genet       Date:  2011-03-02

3.  Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.

Authors:  Yan Xing; Yulia Bronstein; Merrick I Ross; Robert L Askew; Jeffrey E Lee; Jeffrey E Gershenwald; Richard Royal; Janice N Cormier
Journal:  J Natl Cancer Inst       Date:  2010-11-16       Impact factor: 13.506

Review 4.  Short version of the Guideline: Early Detection of Breast Cancer in Germany. An evidence-, consensus-, and outcome-based guideline according to the German Association of the Scientific Medical Societies (AWMF) and the German Agency for Quality in Medicine (AeZQ).

Authors:  U-S Albert; K-D Schulz
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-18       Impact factor: 4.553

5.  The emerging role of national academies in surgical training: an inspiring environment for increasing the quality of health care in breast cancer management.

Authors:  Osman Cem Yilmaz; Nuh Zafer Cantürk; Abut Kebudi; Sertaç Ata Güler; Ahmet Erkek; Mahdi Rezai; Bahadir M Güllüoğlu
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

6.  Review of diagnostic imaging modalities for the surveillance of melanoma patients.

Authors:  Yan Xing; Kate D Cromwell; Janice N Cormier
Journal:  Dermatol Res Pract       Date:  2011-08-23

7.  Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003-2007) from Germany as a proof of concept.

Authors:  Sara Y Brucker; Claudia Schumacher; Christoph Sohn; Mahdi Rezai; Michael Bamberg; Diethelm Wallwiener
Journal:  BMC Cancer       Date:  2008-12-02       Impact factor: 4.430

8.  Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care.

Authors:  Sara Y Brucker; Michael Bamberg; Walter Jonat; Matthias W Beckmann; Andreas Kämmerle; Rolf Kreienberg; Diethelm Wallwiener
Journal:  BMC Cancer       Date:  2009-07-14       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.